Pulmonary Embolism After Liver Resection
1 other identifier
observational
500
1 country
1
Brief Summary
Major surgery is associated with a postoperative hypercoagulable state related to the surgical trauma that may lead to thromboembolic complications. To the investigators knowledge, only two series have reported the risk of PE after liver surgery with an incidence of up to 6.3% The purpose of this study is to identify the independent risk factors associated with the development of PE after elective liver surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 4, 2011
CompletedFirst Posted
Study publicly available on registry
December 6, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedDecember 6, 2011
December 1, 2011
5 years
December 4, 2011
December 5, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulmonary embolism
Blood clots in the lungs that may lead to sudden death.
up to January 2012
Secondary Outcomes (3)
Complications
up to January 2012
Length of hospital stay
up to January 2012
Mortality
up to January 2012
Study Arms (1)
Liver resection patients
All patients that underwent elective liver resection for both malignant and benign diseases.
Interventions
Hepatectomy including both minor and major.
Computed Tomography +/- pulmonary angiography
Eligibility Criteria
All consecutive patients that will undergo liver resection for any type of liver disease.
You may qualify if:
- Age \>18 years
- Malignant liver diseases
- Benign liver diseases
You may not qualify if:
- Age \<18 years
- Previous history of thromboembolic events
- Living Donor hepatectomies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beaujon Hospitallead
Study Sites (1)
Prof. Jacques Belghiti
Paris, Clichy, 92110, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jacques Belghiti, MD
Beaujon Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor, Surgeon
Study Record Dates
First Submitted
December 4, 2011
First Posted
December 6, 2011
Study Start
January 1, 2007
Primary Completion
January 1, 2012
Study Completion
January 1, 2012
Last Updated
December 6, 2011
Record last verified: 2011-12